<html>
<head>PUBMED IDs for FAM46C</head>
<body bgcolor='#C5F0F2'><h1>FAM46C</h1><a href='https://pubmed.ncbi.nlm.nih.gov/21478870/'>A diverse range of gene products are effectors of the type I interferon antiviral response.</a> June 22  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21994415/'>Mapping of chromosome 1p deletions in myeloma identifies FAM46C at 1p12 and CDKN2C at 1p32.3 as being genes in regions associated with adverse survival.</a> June 12  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/23657602/'>Transcriptome meta-analysis of peripheral lymphomononuclear cells indicates that gestational diabetes is closer to type 1 diabetes than to type 2 diabetes mellitus.</a> March 13  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24434212/'>Widespread genetic heterogeneity in multiple myeloma: implications for targeted therapy.</a> March 29  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24518206/'>Promiscuous MYC locus rearrangements hijack enhancers but mostly super-enhancers to dysregulate MYC expression in multiple myeloma.</a> October 8  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25302557/'>Targeted sequencing using a 47 gene multiple myeloma mutation panel (M(3) P) in -17p high risk disease.</a> April 2  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25743686/'>Longitudinal analysis of 25 sequential sample-pairs using a custom multiple myeloma mutation sequencing panel (M(3)P).</a> July 25  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25976968/'>Advances in the pathogenesis and diagnosis of multiple myeloma.</a> April 2  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/27060136/'>FAM46 proteins are novel eukaryotic non-canonical poly(A) polymerases.</a> April 10  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/27720938/'>Identification of gene expression profiling associated with erlotinib-related skin toxicity in pancreatic adenocarcinoma patients.</a> October 11  2016<br></body></html>
